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background: Intravenous loop diuretics (IVLD) are the most commonly used medication for hospitalized congestive heart failure (CHF) patients; 
however, many questions remain regarding their best use. Our objective was to determine if there was any difference in the 30 day readmission rates 
between patients admitted with CHF that received IVLD within 24 hours of discharge and those who were transitioned to stable oral dosing (SOD) at 
least 24 hours prior to discharge.
methods: We performed a retrospective chart review on all patients admitted to our CHF unit from 9/1/2009 to 1/13/2013 using our existing Get 
With the Guidelines® database and our electronic medical record to determine the timing of the patient’s last IVLD dose.
results: The mean age, sex, and ejection fraction was evenly distributed between groups. Patients with renal dysfunction were more likely to be 
on SOD for at least 24 hours prior to discharge and mean length of stay was shorter in the group that did not receive this transition. There was no 
difference in readmission rates when comparing patients on SOD for at least 24 hours (Group 1) vs. those that were transitioned to oral diuretics on 
the day of discharge (Group 2).
conclusions: We did not find any difference in the 30 day readmission rate between those receiving IVLD within 24 hours of discharge and those 
on SOD. Further study is needed to identify which populations can safely be discharged with late transition to oral diuretics and whether different 
post discharge strategies will impact outcomes
Group 1
n = 1575
Group 2
n = 604
p
Age 74.4 73.4 0.17
Male Gender 820 (52%) 308 (51%) 0.67
LVEF<40% 682 (43%) 262 (43%) 0.95
Mean Ejection Fraction (%)mg/dL) 40.8 40.4 0.73
Ischemic CHF 852 (54%) 324 (54%) 0.85
Chronic Kidney Disease
(Baseline Serum Creatinine ≥2 mg/dL)
197 (13%) 34 (6%) 0.00002
Mortality Risk Score at Discharge (%) 3.76 3.41 0.07
Length of Stay (days) 8.86 6.92 0.00009
30d readmission rate 357 (23%) 120 (20%) 0.16
